Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2020

Oct 27, 2020

SELL
$2.18 - $2.84 $436 - $568
-200 Reduced 11.11%
1,600 $0
Q2 2020

Jul 22, 2020

BUY
$1.83 - $4.06 $1,464 - $3,247
800 Added 80.0%
1,800 $1,000
Q4 2018

Feb 05, 2019

BUY
$2.66 - $15.93 $2,660 - $15,930
1,000 New
1,000 $9,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.